General Information of DTT (ID: TTMHA6L)

DTT Name T-cell surface glycoprotein CD8 (CD8) DTT Info
Gene Name CD8A

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluoropeptide vaccine DMCEUOH Influenza virus infection 1E30-1E32 Phase 2 [1]
Anti-VEGFR2 CD8 cell therapy DM2910G Solid tumour/cancer 2A00-2F9Z Phase 1/2 [2]
LIPO-4 DMJRALD Human immunodeficiency virus infection 1C62 Phase 1 [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 A novel peptide-based pan-influenza A vaccine: a double blind, randomised clinical trial of immunogenicity and safety. Vaccine. 2015 Jan 3;33(2):396-402.
2 Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy. Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17561-6.
3 Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16). Vaccine. 2013 Sep 13;31(40):4406-15.